Nine Ten Partners’s Utah Medical Products UTMD Stock Holding History

Nine Ten Partners’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$16.3M	Buy	+271,139	New	+$15M	5.29%	8

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $233M AUM 24.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nine Ten Partners's UTMD Position: Q4 2014 in Review

Nine Ten Partners opened a new position in Utah Medical Products (UTMD) in Q4 2014: 271,139 shares worth $16.3M. The stake represents 5.29% of the portfolio and ranks #8 among its holdings.

60 funds tracked by Wall St. Rank hold UTMD as of Q4 2014.

Nine Ten Partners held 271,139 shares of Utah Medical Products worth $16.3M as of Q4 2014.
Utah Medical Products was a new Nine Ten Partners position in Q4 2014.
Utah Medical Products made up 5.29% of Nine Ten Partners's portfolio in Q4 2014, its #8 holding.
60 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2014.

Based on Nine Ten Partners's 13F filing for Q4 2014, filed 17 Feb 2015.